Similar articles for PMID: 35093921

Year	Number of Results
2002	1
2003	2
2004	1
2008	2
2010	1
2011	2
2012	7
2013	7
2014	6
2015	11
2016	10
2017	4
2018	8
2019	11
2020	20
2021	26
2022	35
2023	12
2024	0

1

Efficacy and Safety of Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Living Donor Liver Transplantation: A Report of Two Cases.

Ichida A, Akamatsu N, Nagata R, Mihara Y, Kawaguchi Y, Bae SK, Ishizawa T, Kaneko J, Arita J, Hasegawa K. Ichida A, et al. Anticancer Res. 2022 Feb;42(2):1161-1167. doi: 10.21873/anticanres.15581. Anticancer Res. 2022. PMID: 35093921

2

Efficient multiple treatments including molecular targeting agents in a case of recurrent hepatocellular carcinoma, post-living donor liver transplantation.

Suzuki R, Goto R, Kawamura N, Watanabe M, Ganchiku Y, Hatanaka KC, Hatanaka Y, Kamiyama T, Shimamura T, Taketomi A. Suzuki R, et al. Clin J Gastroenterol. 2022 Aug;15(4):755-764. doi: 10.1007/s12328-022-01643-3. Epub 2022 May 30. Clin J Gastroenterol. 2022. PMID: 35635645

3

Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.

Kim JM, Kwon CH, Joh JW, Choi MS, Lee JH, Koh KC, Paik SW, Kim GS, Kim SJ, Lee SK, Yoo BC. Kim JM, et al. Transplant Proc. 2012 Mar;44(2):403-8. doi: 10.1016/j.transproceed.2012.01.067. Transplant Proc. 2012. PMID: 22410028

4

Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation.

Waghray A, Balci B, El-Gazzaz G, Kim R, Pelley R, Narayanan Menon KV, Estfan B, Romero-Marrero C, Aucejo F. Waghray A, et al. Clin Transplant. 2013 Jul-Aug;27(4):555-61. doi: 10.1111/ctr.12150. Epub 2013 Jun 13. Clin Transplant. 2013. PMID: 23758296

5

Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Yasuda S, Toyoda H, Fukunishi S, Ohama H, Kawata K, Nakamura S, Nouso K, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y; Real-Life Experts for HCC (RELPEC) Study Group and the HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan). Tada T, et al. Oncology. 2021;99(8):518-527. doi: 10.1159/000515896. Epub 2021 Apr 27. Oncology. 2021. PMID: 33906189

6

Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review.

Qiao ZY, Zhang ZJ, Lv ZC, Tong H, Xi ZF, Wu HX, Chen XS, Xia L, Feng H, Zhang JJ, Xia Q. Qiao ZY, et al. Front Immunol. 2021 Jul 19;12:653437. doi: 10.3389/fimmu.2021.653437. eCollection 2021. Front Immunol. 2021. PMID: 34349755 Free PMC article. Review.

7

Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

de'Angelis N, Landi F, Carra MC, Azoulay D. de'Angelis N, et al. World J Gastroenterol. 2015 Oct 21;21(39):11185-98. doi: 10.3748/wjg.v21.i39.11185. World J Gastroenterol. 2015. PMID: 26494973 Free PMC article. Review.

8

Conversion Hepatectomy for Huge Hepatocellular Carcinoma With Arterioportal Shunt After Chemoembolization and Lenvatinib Therapy.

Sato N, Beppu T, Kinoshita K, Yuki H, Suyama K, Chiyonaga S, Motohara T, Komohara Y, Hara A, Akahoshi S. Sato N, et al. Anticancer Res. 2019 Oct;39(10):5695-5701. doi: 10.21873/anticanres.13768. Anticancer Res. 2019. PMID: 31570469

9

Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation.

Na GH, Hong TH, You YK, Kim DG. Na GH, et al. World J Gastroenterol. 2016 Jul 7;22(25):5790-9. doi: 10.3748/wjg.v22.i25.5790. World J Gastroenterol. 2016. PMID: 27433092 Free PMC article.

10

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma.

Ikeda K, Kudo M, Kawazoe S, Osaki Y, Ikeda M, Okusaka T, Tamai T, Suzuki T, Hisai T, Hayato S, Okita K, Kumada H. Ikeda K, et al. J Gastroenterol. 2017 Apr;52(4):512-519. doi: 10.1007/s00535-016-1263-4. Epub 2016 Oct 4. J Gastroenterol. 2017. PMID: 27704266 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

146 results

Results by year